Skip to content

Scientific poster: Development and characterization of human iPSC-derived 3D neurospheres for disease modeling and drug discovery

3D neurospheres developed with human iPSC-derived astrocytes and cortical neurons and optimized for disease modeling and drug screening
TAKE THE FIRST STEP
MPS poster

Induced pluripotent stem cells (iPSCs) can be differentiated and culture to generate
iPSC-derived 3D neurospheres to better recapitulate the biology, morphology and molecular
dynamics observed in vivo. Additionally, these models can be developed from patient-derived
iPSCs, thus increasing their relevance and predictability.

Here we describe our iPSC platform for cell differentiation at high volumes of Ncyte® Astrocytes
and Ncyte® Cortical neurons and how we used them to develop 3D neurospheres amenable for
high-throughput screening. 

This assay platform shows promise in:

- Modeling in vitro relevant neurodegenerative diseases like Alzheimer's and Parkinson's disease.

- Performing with high robustness to be integrated in drug screening

- Protocol can be easily adapted to patient derived iPSC lines for disease modeling, target identification and screening to support you through your drug discovery process




ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the poster by filling out the form below: